title: [What can medicine expect from health economics?].
abstract: Medicine has changed dramatically in the past ten decades thanks to the introduction of innovative diagnostic and therapeutic procedures. However, besides the unmistakable advances achieved in medicine, the costs of all health care systems have risen dramatically. In contrast to the escalation in expenditures, only moderate gains in proceeds have been accomplished. This situation requires that future financial resources be judiciously expended. The field of health economics has set as its goal the analysis of medical measures in terms of costs and benefits to be able to provide information on these parameters to those involved in the public health sector. The emerging problems are diverse and extend from assessment of effects and side effects to difficulties in standardizing analytical procedures and comparing results between different health care systems.In the context of this manuscript an attempt has been made to illustrate the methodological approaches to health economics based on current issues in the diagnosis and treatment of prostate cancer. This contribution intends to motivate stakeholders to view health economics as a tool to promote improvements in medical care and not as a means to regulating and rationing medical measures.
authors.affiliation: Urologie, EuromedClinic und Urologie24, c/o Europa-Allee 1, 90763, Fürth, Deutschland.
authors.forename: E
authors.initials: E
authors.lastname: Bismarck
authors.forename: B J
authors.initials: BJ
authors.lastname: Schmitz-Dräger
authors.forename: O
authors.initials: O
authors.lastname: Schöffski
mesh_terms: D003363:Cost Control / Q000379:methods; D004470:Economics, Medical; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D015276:Health Care Rationing / Q000191:economics*; D006801:Humans; D008297:Male; D015995:Prevalence; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000191:economics / Q000628:therapy